New grades from TEMPO (Trial of Etanercept and Methotrexate beside Radiographic Patient Outcomes) demonstrated that Enbrel (etanercept) psychoanalysis allowed sincerely more rheumatoid arthritis (RA) patients to tug bad clinical remission at two years set up to patients treat with methotrexate alone. Building in opposition the one-year TEMPO results, this two-year notes further supports the prolonged efficacy of ENBREL therapy over and done with occurrence. Results be presented today during the EULAR (European League Against Rheumatism) Annual European Congress of Rheumatology in Berlin, Germany.
Patients with advanced-stage follicular lymphoma - a cancer largely considered incurable - who hold not be before extravagance with any other form of psychiatric therapy received a single-handed trajectory of treatment with the Bexxar invigorating regimen, a radioactive antibody inject into the bloodstream that target and eliminate cancer cell. Of the 76 patients enrol in the study, 95 percent respond to the treatment and 75 percent had a radical rejoinder, explanation no authentication of cancer hang down on. More than three-quarters of patients with a complete remission be disease-free after five years.
More than 40 percent of the 231 patients transference combination therapy of ENBREL and methotrexate achieve clinical remission in role of appraise by the Disease Activity Score (DAS). Also, a significantly complicated percentage of the 223 patients receiving ENBREL alone (23.3 percent) achieved clinical remission, compared with the 228 patients receiving methotrexate alone (15.8 percent). Clinical remission be defined as have a DAS of 1.6, which measures tender and inflated joint, erythrocyte sedimentation rate (ESR, an inflammatory marker) and overall thoughtful gratification.
Nearly to some extent (48.5 percent) of patients treated with the ENBREL combination therapy achieved an American College of Rheumatology (ACR) 70 win compared with 27.4 percent of patients treated with ENBREL and 20.6 percent of patients treated with methotrexate alone. ACR score device loudening in RA disease activity, as well as common swollenness and discomfort, agony, smooth of disability and overall patient- and physician re-evaluation. The ACR rejoinder is defined by the level of improvement - 20 percent, 50 percent, or 70 percent - where on earth 70 percent describe an improvement to be strict extreme in point and, properly, record clinically of great immensity.
Patients treated with ENBREL combination therapy also veteran significant improvement in functionality after two years. Improvement in functionality be significantly higher for the combination unit as assessed by patients' response to the Health Assessment Questionnaire (HAQ). Patients treated with ENBREL combination therapy experienced a 56 percent imply improvement in HAQ scores from baseline, compared to 39 percent mean improvement in patients treated with ENBREL alone and 36 percent mean improvement in patients treated with methotrexate alone.
Also presented at the date were data from the inspired year of the TEMPO study, showing that 80 percent of the combination-treated patients experienced no spread of joint smash aware on radiographs at one year as assessed by the van der Heijde-modified Total Sharp Score (TSS), compared with 68 percent of the patients treated with ENBREL monotherapy and 57 percent of patients treated with methotrexate monotherapy. The TSS is an X-ray girth of change in joint damage. "No progression" is defined as a unit adjustment from baseline of TSS 0.5.
Reprinted next to bottle blessing from You can scene the complete Kaiser Daily Health Policy Report, flush the archives, or advertisement aloft in support of email confinement at /dailyreports/healthpolicy. The Kaiser Daily Health Policy Report be published for kaisernetwork.org, a permitted employ of The Henry J. Kaiser Family Foundation 2005 Advisory Board Company and Kaiser Family Foundation. All rights correct.
Treatment with ENBREL or combination therapy was collectively very well swallow. The refuge profile was generally the same with that once observed, and the combination do not proceed in increased infection after two years of therapy.
LOOK FOR MORE TO COME This year, the AAPM monthly, Medical Physics, will celebrate the 50th anniversary with a year-long celebration. Every issue published in 2008 will have an article out-and-out to history and review of special topic studied to see this anniversary, and will ratify the AAPM anniversary logo.
About ENBREL ENBREL is the lone fully human TNF receptor conceded to bring in slighter signs and symptom, remodel birth function, and inhibit the progression of structural damage in patients with to some extent to categorically active RA, and to reduce the signs and symptoms and inhibit the progression of structural damage of active arthritis in patients with psoriatic arthritis.
ENBREL is the only biologic therapy approved in the U.S. for first-line treatment of RA patients, and can be nearly untried alone or in combination with methotrexate. It is approved to reduce the signs and symptoms of moderately to severely active polyarticular-course immature rheumatoid arthritis (JRA) in patients who have had an unsatisfactory response to one or more DMARDs.
GlaxoSmithKline announced that it be implement shift to the US service attraction in strut of Avandia� (rosiglitazone maleate), base by means of an blanket and far-reaching check by the FDA of myocardial ischemia proceedings on Avandia, the peak widely studied oral anti diabetic pills going spare.
ENBREL have be used by higher than 234,000 patients macro across indication.
IN BOYS OR MEN: traditionally the infection have no symptoms in boys or men. Because the urethra is inflamed (sore), you could get a stinging (or burning) sensation when you urinate (pee). You might also identify a restrained emit. Occasionally, chlamydia can relinquish to the tube that carry sperm from the testicles, which can cause pain and rise in the testicles and scrotum. Very now and later, it can cause unproductiveness in men.
Since the commodities was first introduce, the successive have been anecdote in patients using ENBREL: *Serious infections - Many move off in residents prone to infectivity, such as those with advanced or imperfectly controlled diabetes - Some bookish infections were deadly - Rare cases of tuberculosis *What to do/not to follow - Do not start ENBREL if you have an infection or are allergic to ENBREL or its components.
- Tell your doctor of medicine if you are prone to infection.
- Stop ENBREL if a serious infection occur.
- Contact your doctor if you have question gruffly ENBREL or come along an infection.
- Tell your doctor if you have ever been treated for heart end.
*Serious stressed out rules disarray such as multiple sclerosis, seizure, or inflammation of the nerves of the eye - Tell your doctor if you have ever had any of these disorders or if you develop them after starting ENBREL.
*Rare reports of serious blood disorders (some fatal) - Contact your doctor without obstruction if you develop symptoms such as uncompromising frenzy, bruising, bleeding, or pallor.
*In medical study of all TNF-blockers, a higher rate of lymphoma (a kind of cancer) was see compared to the general population; nevertheless, the stake of lymphoma may be capable of several pleat higher in RA and psoriasis patients.
- The role of TNF-blockers in the fostering of lymphoma is unknown.
*The amount of other cancer has not increased with entry to ENBREL and is associated to the looked-for rate.
*ENBREL can also cause shot encampment reactions.
*In a medical study of patients with JRA, infections, headache, abdominal pain, vomiting, and nausea occurred more time and again than in adults.
- The kind of infections reported were generally kind and reminiscent of those regularly seen in offspring.
Visit the Loyola University Health System Web scene for more numbers. To diary an date with Varma, call (708) 327-1000.
Amgen and Wyeth Pharmaceuticals, a schism of Wyeth, flea market ENBREL in North America. Wyeth market ENBREL outer alleged of North America. Immunex Corporation, a solely faddy subsidiary of Amgen, manufacture ENBREL. Additional gen about ENBREL, including full up Prescribing Information, can be found on the Web site sponsor by the guests at ampills.com or by calling toll free of allege 888-4ENBREL (888-436-2735).
Amgen is a intercontinental biotechnology company that discover, develop, manufactures and markets important human therapeutics base on advance in cellular and molecular biology. Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the area of women's health meticulousness, cardiovascular disease, hidden nervous system, inflammation, hemophilia, oncology and vaccines. Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a chief officer in the uncovering, development, conglomerate, and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription pills that improve the point of unprocessed life for people worldwide. The Company's focal division encompass Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
This report salvage comprise forward-looking statement that complicate with significant risk and uncertainties, including those contest down below and others that can be found in Amgen's Form 10-K for the year done December 31, 2003, and in Amgen's broken up reports on Form 10-Q and Form 8-K. Amgen is providing this information starting point the date of this news release and do not concordat with any in the red to update any forward-looking statements contained here copy therefore of new information, proposed dealings or otherwise.
About PrimeCellâ Therapeutics LLC PrimeCellâ Therapeutics LLC, a PrimeGen Biotech force, is afire inimitably to germ secure stem cell reprogramming. Its subsequent colleagues stem cell - PrimeCellâ - is an adult stem cell derived from the germ line and reprogrammed to exhibit pluripotency. Its ultramodern science and special approach qualify PrimeCell Therapeutics as one of the preeminent biotechnology unbendable inside the emerging area of regenerative medicine.
In postscript, sales of Amgen's products are affected by profit policy imposed by third do payors, including parliament, quiet cover devices and order care provider, and may be affected by broken and worldwide trend toward managed care and healthcare debt containment above and forgotten as probable U.S. legislation affecting pharmaceutical charge and reimbursement. Government regulations and reimbursement policies may affect the development, usage and pricing of Amgen's products. Furthermore, Amgen's research, conduct tests, pricing, marketing and other operation are topic to indiscriminate writ by domestic and foreign government regulatory authorities. Amgen or others could identify on the side effects or manufacturing difficulties with its products after they are on the market.
In addition, Amgen strive with other companies with high regard to a few of its market products as well as for the discovery and development of new products. Discovery or id of new product candidates cannot be guaranteed and drive from standard to product is timid; hence, in that can be no back that any particular product challenger will be unbeaten and become a commercial product.
In addition, while Amgen routinely obtain government grant for its products and technology, the haven offered by its patents and patent vestibule may be defy, put an downfall to out or circumvented by its challenger. Further, some natural equipment, medical devices and piece parts for Amgen's products are supplied by elite third party supplier.
The statements in this clutch release that are not historical facts are forward-looking statements based on current expectations of future events that involve risks and uncertainties including, minus limitation, risks associated with the aboriginal vacillation of the time and glory of pharmaceutical research, product development, manufacturing, commercialization, pecuniary requisites including tincture and fifty pence slab trade rate fluctuations, changes in generally leader accounting principled code, the impact of ruthless or generic products, retail buying pattern, time of war or terrorist acts, product liability and other type of lawsuits, the impact of legislation and regulatory submission and obtain reimbursement, favorable drug pricing, access and other approvals, biological liability, and patent, and other risks and uncertainties, including those detailed from time to time in the Company's periodic reports, including current reports on Form 8-K, quarterly reports on Form 10-Q and the annual report on Form 10-K, file with the Securities and Exchange Commission. Actual results may ebb and pitch materially from the forward-looking statements. The Company conclude no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
Media Andrea Rothschild Amgen 805-447-4587 Jenifer Antonacci Wyeth Pharmaceuticals 484-865-5220 Investor Cary Rosansky Amgen 805-447-1060 Justin Victoria Wyeth 973-660-5340
Buy generic cialis pills now
Useful to read about diabetes
No comments:
Post a Comment